JP6606100B2 - 機能的細胞状態の同定 - Google Patents

機能的細胞状態の同定 Download PDF

Info

Publication number
JP6606100B2
JP6606100B2 JP2016563912A JP2016563912A JP6606100B2 JP 6606100 B2 JP6606100 B2 JP 6606100B2 JP 2016563912 A JP2016563912 A JP 2016563912A JP 2016563912 A JP2016563912 A JP 2016563912A JP 6606100 B2 JP6606100 B2 JP 6606100B2
Authority
JP
Japan
Prior art keywords
cells
cell
tensor
response
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016563912A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017505140A (ja
JP2017505140A5 (enExample
Inventor
ラジワ，バルトロミェイ
シャンキー，ティー．ヴィンセント
Original Assignee
アセダサイエンシズ アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アセダサイエンシズ アーゲー filed Critical アセダサイエンシズ アーゲー
Publication of JP2017505140A publication Critical patent/JP2017505140A/ja
Publication of JP2017505140A5 publication Critical patent/JP2017505140A5/ja
Application granted granted Critical
Publication of JP6606100B2 publication Critical patent/JP6606100B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00—Subject matter not provided for in other groups of this subclass
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/40—Searching chemical structures or physicochemical data
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C99/00—Subject matter not provided for in other groups of this subclass

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Computing Systems (AREA)
  • Physiology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
JP2016563912A 2014-01-14 2015-01-14 機能的細胞状態の同定 Active JP6606100B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461927247P 2014-01-14 2014-01-14
US61/927,247 2014-01-14
PCT/US2015/011441 WO2015109003A1 (en) 2014-01-14 2015-01-14 Identification of functional cell states

Publications (3)

Publication Number Publication Date
JP2017505140A JP2017505140A (ja) 2017-02-16
JP2017505140A5 JP2017505140A5 (enExample) 2018-02-15
JP6606100B2 true JP6606100B2 (ja) 2019-11-13

Family

ID=52440877

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016563912A Active JP6606100B2 (ja) 2014-01-14 2015-01-14 機能的細胞状態の同定

Country Status (11)

Country Link
US (3) US11137388B2 (enExample)
EP (1) EP3094974B1 (enExample)
JP (1) JP6606100B2 (enExample)
KR (1) KR102413041B1 (enExample)
AU (2) AU2015206520B2 (enExample)
CA (1) CA2972960C (enExample)
DK (1) DK3094974T3 (enExample)
ES (1) ES2728119T3 (enExample)
IL (1) IL246734B (enExample)
SG (1) SG11201705495XA (enExample)
WO (1) WO2015109003A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3094974B1 (en) * 2014-01-14 2019-02-27 Asedasciences AG Identification of functional cell states
CA2977481C (en) 2015-02-24 2021-02-02 The University Of Tokyo Dynamic high-speed high-sensitivity imaging device and imaging method
EP3372985B1 (en) 2015-10-28 2025-06-25 The University Of Tokyo Analysis device
US10824693B2 (en) 2015-12-10 2020-11-03 Reservoir Labs, Inc. Systems and methods for selective expansive recursive tensor analysis
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
US12300357B2 (en) 2016-12-14 2025-05-13 FlowJo, LLC Applied computer technology for management, synthesis, visualization, and exploration of parameters in large multi-parameter data sets
US11573182B2 (en) 2017-05-25 2023-02-07 FlowJo, LLC Visualization, comparative analysis, and automated difference detection for large multi-parameter data sets
WO2019241443A1 (en) 2018-06-13 2019-12-19 Thinkcyte Inc. Methods and systems for cytometry
US11972858B2 (en) 2019-05-14 2024-04-30 University Of Pittsburgh-Of The Commonwealth System Of Higher Education System and method for characterizing cellular phenotypic diversity from multi-parameter cellular, and sub-cellular imaging data
EP4083603A4 (en) 2019-12-27 2024-04-03 ThinkCyte, Inc. FLOW CYTOMETER PERFORMANCE EVALUATION METHODS AND STANDARD PARTICLE SUSPENSION
WO2021200960A1 (ja) 2020-04-01 2021-10-07 シンクサイト株式会社 観察装置
WO2021200911A1 (ja) 2020-04-01 2021-10-07 シンクサイト株式会社 フローサイトメーター
WO2022026532A1 (en) * 2020-07-30 2022-02-03 Allen Institute Systems, devices, and methods for compound screening using predictive tagging
US20240337647A1 (en) 2021-07-26 2024-10-10 Asedasciences Ag Improved methods for identification of functional cell states
WO2023056481A1 (en) * 2021-10-01 2023-04-06 CAP Diagnostics, LLC, dba Pathnostics Automated methods and systems for rapid identification of target particles
US12105081B2 (en) * 2021-10-20 2024-10-01 Travera, Inc. Treatment response assessment using normalized single cell measurements
IL322273A (en) 2023-01-23 2025-09-01 Asedasciences Ag Improved human-computer interaction systems

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5544650A (en) * 1988-04-08 1996-08-13 Neuromedical Systems, Inc. Automated specimen classification system and method
AU6024294A (en) 1993-01-08 1994-08-15 Coulter Corporation Method of using preserved control cells in the calibration of fluorescent and light scatter measurements
CA2196496A1 (en) 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
US20050221280A1 (en) 1998-02-02 2005-10-06 Odyssey Thera, Inc. Protein-protein interactions for pharmacological profiling
US7166424B2 (en) 1998-02-02 2007-01-23 Odyssey Thera Inc. Fragments of fluorescent proteins for protein fragment complementation assays
US6801859B1 (en) 1998-12-23 2004-10-05 Rosetta Inpharmatics Llc Methods of characterizing drug activities using consensus profiles
US6998249B1 (en) 1999-09-27 2006-02-14 Pharmacia & Upjohn Company Toxicity screening method
WO2001067103A1 (en) 2000-03-06 2001-09-13 Bioseek, Inc. Function homology screening
EP1290428A1 (en) 2000-06-02 2003-03-12 Medicometrics APS Method and system for classifying a biological sample
US7146349B2 (en) * 2000-11-06 2006-12-05 International Business Machines Corporation Network for describing multimedia information
WO2004094609A2 (en) 2003-04-23 2004-11-04 Bioseek, Inc. Methods for characterizing signaling pathways and compounds that interact therewith
US20070135997A1 (en) 2003-04-23 2007-06-14 Evangelos Hytopoulos Methods for analysis of biological dataset profiles
WO2008134593A1 (en) * 2007-04-25 2008-11-06 President And Fellows Of Harvard College Molecular circuits
WO2009146036A2 (en) * 2008-04-01 2009-12-03 Purdue Research Foundation Quantification of differences between measured values and statistical validation based on the differences
US20130226469A1 (en) 2008-04-01 2013-08-29 Purdue Research Foundation Gate-free flow cytometry data analysis
EP3094974B1 (en) * 2014-01-14 2019-02-27 Asedasciences AG Identification of functional cell states

Also Published As

Publication number Publication date
US11137388B2 (en) 2021-10-05
DK3094974T3 (da) 2019-05-27
AU2021204419A1 (en) 2021-07-22
US11867690B2 (en) 2024-01-09
JP2017505140A (ja) 2017-02-16
US20160370350A1 (en) 2016-12-22
KR102413041B1 (ko) 2022-06-23
ES2728119T3 (es) 2019-10-22
KR20160110444A (ko) 2016-09-21
CA2972960A1 (en) 2015-07-23
US20210364499A1 (en) 2021-11-25
AU2015206520B2 (en) 2021-07-22
SG11201705495XA (en) 2017-08-30
EP3094974B1 (en) 2019-02-27
EP3094974A1 (en) 2016-11-23
AU2015206520A1 (en) 2016-07-14
IL246734A0 (en) 2016-08-31
WO2015109003A1 (en) 2015-07-23
HK1231553A1 (en) 2017-12-22
US20150198584A1 (en) 2015-07-16
IL246734B (en) 2019-06-30
CA2972960C (en) 2022-01-11

Similar Documents

Publication Publication Date Title
US11867690B2 (en) Identification of functional cell states
Way et al. Predicting cell health phenotypes using image-based morphology profiling
O'Neill et al. Flow cytometry bioinformatics
US20240337647A1 (en) Improved methods for identification of functional cell states
EP4214675A1 (en) Methods and systems for predicting neurodegenerative disease state
JP2013529891A (ja) 無標識オンターゲット薬理学方法
ES2359449T3 (es) Métodos para identificar condiciones que afectan a un estado celular.
Bourn et al. Evaluation of image analysis tools for the measurement of cellular morphology
US20050282208A1 (en) Cellular phenotype
Babamoradi et al. Quality assessment of boar semen by multivariate analysis of flow cytometric data
HK1231553B (en) Identification of functional cell states
US20050014131A1 (en) Methods and apparatus for investigating side effects
US20070082327A1 (en) Cellular phenotype
Frey et al. Single-Cell Morphological Profiling Reveals Insights into Programmed Cell Death
JP2018529944A (ja) インビトロ実験を用いて化学的または生物学的作用物へのインビボ反応の発生率を推定する方法
Schauer et al. A novel organelle map framework for high-content cell morphology analysis in high throughput
US20230137843A1 (en) Holographic video microscopy cell viability assay
US20250246259A1 (en) Method for predictive testing of agents to assess triggering and suppressing adverse outcomes and/or diseases
Aghaeepour et al. Flow cytometry bioinformatics
Strassner et al. Relationships between metabolism of cryopreserved equine sperm determined by the Seahorse Analyzer and sperm characteristics measured by flow cytometry and computer assisted analysis of motility
CN108267571A (zh) 一种血液种属判别的方法
Alsuwailem Improved drug activity in high-content screening of the microtubule network
Castelló et al. Metabolic profile of day 3 embryos arising from vitrified oocytes
Padfield et al. Validation Methods for Cell Cycle Analysis Algorithms in Confocal Fluorescence Images
Mattingly Mathematical Models for Understanding Dynamic Cellular Systems

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20170511

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170511

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171227

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171227

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20181031

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181120

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190509

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20191008

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20191017

R150 Certificate of patent or registration of utility model

Ref document number: 6606100

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250